These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2007-000513-12 Terlipressin in the treatment of catecholamine-resistant septic shock not-yet-due
Ongoing 2010-022681-27 Ofatumumab Added to Dexamethasone in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia not-yet-due
Listed as ongoing, but also has a completion date 2011-000440-22 MULTICENTER TRIAL ESTIMATING THE PERSISTANCE OF MOLECULAR REMISSION IN CHRONIC MYELOID LEUKAEMIA AFTER STOPPING TKI 2017-11-20 bad-data
Not reported 2014-002168-34 Study To Determine Efficacy of Aflibercept For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration Stanovení účinnosti Afliberceptu v léčbě zmnožení cév uvn... 2019-11-22 due-trials
Ongoing 2018-002267-25 SAFETY AND EFFICACY OF OLANZAPINE TREATMENT IN PSYCHOSIS: EFFECT OF GENETIC AND EPIGENETIC FACTORS – COVARIATES OF TREATMENT RESPONSE BEZPEČNOST A ÚČINNOST TERAPIE OLANZAPINEM U PSYCHÓZ: VLIV GENET... not-yet-due
No trial status on register 2020-002046-16 A Randomised, double-blinded, placebo-controlled, multicenter study of efficacy, safety and side effects of highly diluted atropine collyrium in slowing the progression of myopia (shortsightedness) in... bad-data
Ongoing 2020-005887-70 Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomized controlled trial Účinek dexamethasonu u pacientů s ARDS a COVID-19 – ... not-yet-due